TipRanks
Spencer Pharmaceutical (SPPH)
OTHER OTC:SPPH
US Market

Spencer Pharmaceutical (SPPH) Income Statement

9 Followers

Spencer Pharmaceutical Income Statement

Last quarter (Q0 0), Spencer Pharmaceutical's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Spencer Pharmaceutical's net income was $-509.69K. See Spencer Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 03Dec 02Dec 01
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 10.07K$ 4.55K
EBITDA
$ -862.54K$ -2.23M$ -1.01M
Operating Income
$ -862.54K$ -2.28M$ -2.24M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -862.54K$ -2.24M$ -2.23M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
― ― ―
Weighted Average Shares Outstanding (Diluted)
― ― ―

Spencer Pharmaceutical Earnings and Revenue History